Association of human papillomavirus with vulvar and vaginal intraepithelial disease: Opportunities for prevention

J. Matt Pearson, Richard S. Feltman, Leo B Twiggs

Research output: Contribution to journalReview article

1 Scopus citations

Abstract

While the majority of studies regarding the health benefits from human papillomavirus (HPV) vaccination have focused on cervical neoplasia and cancer, few have investigated how the epidemiology of vaginal and vulvar disease may be affected. To better understand how occurrence rates for vaginal and vulvar neoplasias and carcinomas may change in the future, we must have an understanding of the overall disease prevalence within a given population, the efficacy of vaccination and the proportion of cases attributable to HPV types administered in the vaccine. In this review, we will examine basic HPV epidemiology and prevalence, the molecular transformation events carried out by HPV oncoproteins, and clinical trials monitoring HPV-induced disease of the female genital tract. While precise projections of exactly how vaginal and vulvar disease prevalence will change with vaccination will require more studies, the preliminary data are promising.

Original languageEnglish (US)
Pages (from-to)143-150
Number of pages8
JournalWomen's Health
Volume4
Issue number2
DOIs
StatePublished - Mar 1 2008

Keywords

  • Cancer
  • HPV
  • Vaccine
  • Vagina
  • Vulva

ASJC Scopus subject areas

  • Medicine(all)

Fingerprint Dive into the research topics of 'Association of human papillomavirus with vulvar and vaginal intraepithelial disease: Opportunities for prevention'. Together they form a unique fingerprint.

  • Cite this